Canton Strategic Holdings (CNTN) Other Working Capital Changes (2021 - 2026)
Canton Strategic Holdings' (CNTN) quarterly Other Working Capital Changes came in at $1.2 million in Q1 2026, up 183.57% YoY from $423103.0 in Q1 2025, and up 353.99% on a QoQ basis from $264280.0 in Q4 2025.
Analysis
Canton Strategic Holdings (CNTN) Other Working Capital Changes (2021 - 2026) Analysis & Trends
Canton Strategic Holdings (CNTN) has 6 years of Other Working Capital Changes data on file, last reported at $1.2 million in Q1 2026.
- Quarterly Other Working Capital Changes rose 183.57% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 million (up 12876.96% YoY) and the FY2025 annual result came in at $308055.0, up 800.17% from the prior year.
- Other Working Capital Changes climbed to $1.2 million in Q1 2026, from $264280.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $1.2 million in Q1 2026 to a low of -$382485.0 in Q3 2023.
- A 5-year average of $87202.4 and a median of -$158387.0 in 2024 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 2208.44% in 2022, down 30833.0% in 2022.
- Tracing CNTN's Other Working Capital Changes over 5 years: stood at -$243496.0 in 2022, then fell by 23.96% to -$301849.0 in 2023, then dropped by 4.27% to -$314746.0 in 2024, then jumped by 183.97% to $264280.0 in 2025, then jumped by 353.99% to $1.2 million in 2026.
- The last three Other Working Capital Changes figures came in at $1.2 million (Q1 2026), $264280.0 (Q4 2025), and -$106980.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Canton Strategic Holdings | 493.37 Mn | 493.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -435,761.00 |
| Jun 30, 2026 | -435,761.00 |
| Mar 31, 2026 | 1.20 Mn |
| Mar 31, 2026 | 1.20 Mn |
| Dec 31, 2025 | 264,280.00 |
| Dec 31, 2025 | 264,280.00 |
| Sep 30, 2025 | -106,980.00 |
| Sep 30, 2025 | -106,980.00 |
| Jun 30, 2025 | -272,348.00 |
| Jun 30, 2025 | -272,348.00 |
| Mar 31, 2025 | 423,103.00 |
| Mar 31, 2025 | 423,103.00 |
| Dec 31, 2024 | -314,746.00 |
| Dec 31, 2024 | -314,746.00 |
| Sep 30, 2024 | 58,389.00 |
| Sep 30, 2024 | 58,389.00 |
| Jun 30, 2024 | -158,387.00 |
| Jun 30, 2024 | -158,387.00 |
| Mar 31, 2024 | 448,966.00 |
| Mar 31, 2024 | 448,966.00 |